In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

The AI chip maker’s shares rose more than 5% after hours as quarterly revenue surged to a record $44 billion.

Hang Seng Index approached a two-month high on bets global trade relations and market sentiment will improve Hong Kong stocks jumped by the most in a week in lockstep with major equity markets in the ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

The US is dangerously close to falling behind China in biotech, and the government should spend a minimum of $15 billion over the next five years to "unleash" private capital for the sector.